https://en.wikipedia.org/wiki/Huma_(company)

https://www.forbes.com/sites/jamessomauroo/2020/04/16/medopad-rebrands-as-huma-and-acquires-two-healthtech-companies/?sh=5574f01a1d32

On 16 April 2020, Medopad announced that it has changed its name to Huma and has acquired two healthtech startups: Biobeats and Tarilian Laser Technologies (TLT) that specialise in AI and wearable technologies. The rebrand and acquisitions give Huma the potential to build on their historical offerings across remote patient monitoring, adding mental health and cardiovascular capabilities and moving into digital biomarkers and therapeutics.

Huma began its journey in 2011 with the vision of leveraging data through remote monitoring to help those with rare diseases. Since then, the company has raised over $50M from Bayer, NWS Holdings and others and partnered with the likes of Apple, Tencent, J&J, Bayer, Johns Hopkins University and UK NHS organisations to monitor and analyse health more broadly.

Talking about Huma's evolving vision, founder and CEO, Dan Vahdat said that he "realised that health is about more than disease states" and that "general physical and mental wellbeing go hand-in-hand," a concept ever more popular as expectations of health rise to include prevention and optimisation rather than merely the absence of disease.

The Acquisitions: Surviving to Thriving

To build a complete picture of a person’s overall health, Huma is acquiring two healthtech startups that use AI and wearables: BioBeats and TLT, in a mix of cash and options.

BioBeats is a UK-based company that builds preventative digital mental health interventions. Its product, BioBase, pairs a mobile app with biosensors and a wearable device, gathering biometric data (e.g. heart rate variability) and psychometric measures (e.g. mood journaling) to improve mental health through tailored insights, biofeedback tools and digital therapeutics.